论文信息 - Panitumumab (pmab) regimen evaluation in colorectal cancer to estimate primary response to treatment (PRECEPT): Effect of KRAS mutation status on second-line treatment (tx) with pmab and FOLFIRI - 字舞流文

Panitumumab (pmab) regimen evaluation in colorectal cancer to estimate primary response to treatment (PRECEPT): Effect of KRAS mutation status on second-line treatment (tx) with pmab and FOLFIRI

David A. Smith | R. Sikorski | M. Yassine | A. Cohn | M. Neubauer | S. Suzuki | R. Deeter | G. Houston | P. Khandelwal | R. Wiggans